Activation of the Peroxisome Proliferator–Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Activation of the Peroxisome Proliferator–Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis

Published:2019-07-03 Issue:8 Volume:71 Page:1252-1264
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Ma Jian‐Da¹,Jing Jun¹,Wang Jun‐Wei¹,Mo Ying‐Qian¹,Li Qian‐Hua¹,Lin Jian‐Zi¹,Chen Le‐Feng¹,Shao Lan²,Miossec Pierre³,Dai Lie¹

Affiliation:

1. Sun Yat‐Sen Memorial HospitalSun Yat‐Sen University Guangzhou China

2. First Affiliated HospitalSun Yat‐Sen University Guangzhou China

3. University of Lyon and Hospices Civils de Lyon Lyon France

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Traditional Chinese Medicine Bureau of Guangdong Province

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40868

Reference43 articles.

1. Rheumatoid arthritis

2. Alternative pathways of osteoclastogenesis in inflammatory arthritis

3. Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems

4. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis — The In Vitro Osteoclast Differentiation in Arthritis (IODA) study

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bu-Shen-Ning-Xin decoction inhibits macrophage activation to ameliorate premature ovarian insufficiency-related osteoimmune disorder <i>via</i> FSH/FSHR pathway;Drug Discoveries & Therapeutics;2024-04-30

2. A Review of Proposed Mechanisms in Rheumatoid Arthritis and Therapeutic Strategies for the Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03

3. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases;Signal Transduction and Targeted Therapy;2024-03-01

4. Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction;Journal of Advanced Research;2024-03

5. In vitro osteoclastogenesis in autoimmune diseases – Strengths and pitfalls of a tool for studying pathological bone resorption and other disease characteristics;Heliyon;2023-11